Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. UnitedHealth Group Incorporated shares valued at $252,201 were sold by ROOS THOMAS E on Aug 26. At $542.37 per share, ROOS THOMAS E sold 465 shares. The insider’s holdings dropped to 34,786 shares worth approximately $18.0 million following the completion of this transaction.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Also, McMahon Dirk C sold 14,715 shares, netting a total of over 7,994,939 in proceeds. Following the sale of shares at $543.32 each, the insider now holds 50,108 shares.
Before that, REX JOHN F had sold 13,183 shares from its account. In a trade valued at $7,138,990, the EVP Chief Financial Officer traded UnitedHealth Group Incorporated shares for $541.53 each. Upon closing the transaction, the insider’s holdings decreased to 13,183 shares, worth approximately $73.22 million.
As published in their initiating research note from Loop Capital on June 17, 2022, UnitedHealth Group Incorporated [UNH] has been a Buy and the price target has been revised to $575. This represents a 10.01% premium over Thursday’s closing price. Analysts at Bernstein downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in late May. As of December 14, 2021, Goldman has initiated its “Buy” rating for UNH. Earlier on September 27, 2021, SVB Leerink initiated its rating. Their recommendation was “an Outperform” for UNH stock.
Analyzing UNH’s Price Performance
On Thursday, UnitedHealth Group Incorporated [NYSE: UNH] rose 1.05% to $517.46. The stock’s lowest price that day was $506.1101, but it reached a high of $520.97 in the same session. During the last five days, there has been a drop of approximately -1.04%. Over the course of the year, UnitedHealth Group Incorporated shares have jumped approximately 3.05%. Shares of the company reached a 52-week high of $553.29 on 04/14/22 and a 52-week low of $445.73 on 02/24/22. A 50-day SMA is recorded $529.83, while a 200-day SMA reached $502.13. Nevertheless, trading volume fell to 2.29 million shares from 2.43 million shares the previous day.
Support And Resistance Levels for UnitedHealth Group Incorporated (UNH)
According to the 24-hour chart, there is a support level at 508.72, which, if violated, would cause prices to drop to 499.99. In the upper region, resistance lies at 523.58. The next price resistance is at 529.71. RSI (Relative Strength Index) is 45.40 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.72, which suggests the price will decrease in the coming days. Percent R is at 60.72%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is UnitedHealth Group Incorporated subject to short interest?
Stocks of UnitedHealth Group Incorporated saw a sharp steep in short interest on Jul 14, 2022 dropping by 80000.0 shares to 5.68 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 5.76 million shares. A decline of -1.41% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.33 of the overall float, the days-to-cover ratio (short ratio) decline to 1.33.
Which companies own the most shares of UnitedHealth Group Incorporated (UNH)?
According to The Vanguard Group, Inc. filings, the company currently owns 78,267,730 shares, which is about 8.37% of the total UNH shares outstanding. The investor’s shares have appreciated by 1,342,996 from its previous 13-F filing of 76924734.0 shares. With the completion of the sale transaction, SSgA Funds Management, Inc.’s stake is now worth $23,822,637,728. Fidelity Management & Research Co acquire a 1.89% interest valued at $23.64 billion while BlackRock Fund Advisors purchased a 2,114,445 stake. A total of 5,556,335 shares of UnitedHealth Group Incorporated were bought by T. Rowe Price Associates, Inc. during the quarter, and -684,595 were sold by Capital Research & Management Co. In its current portfolio, Wellington Management Co. LLP holds 26,538,607 shares valued at $13.78 billion.
In terms of UnitedHealth Group Incorporated share price expectations, FactSet research, analysts set an average price target of $586.57 in the next 12 months, up nearly 15.22% from the previous closing price of $512.08. Analysts anticipate UnitedHealth Group Incorporated stock to reach $635.00 by 2022, with the lowest price target being $480.00. In spite of this, 26 analysts ranked UnitedHealth Group Incorporated stock as a Buy at the end of 2022. On September 10, 2021, Cowen assigned a price target of “an Outperform” to the stock and initiated coverage with a $478.